clinical trial
Coverage of clinical trial in the Nexus archive.
- Swallowing faecal capsules reduces peanut allergy in six adults
A clinical trial found that six adults with peanut allergies showed improved tolerance after their gut microbiomes were altered using faecal capsules from an allergy-free donor. The treatment involved modifying gut bacteria through donated faeces to reduce allergic reactions.
- Eli Lilly is allowing more patients early access to its experimental weight loss drug
Eli Lilly is allowing more patients early access to its experimental weight loss drug. The company will review requests from doctors for patients who cannot enroll in clinical trials.
- Grandfather with pancreatic cancer beats the odds with clinical trial
Hernando Salcedo was diagnosed with Stage III pancreatic cancer after mild symptoms. Chemotherapy worsened his condition, but he participated in a clinical trial that helped him beat the odds.
- Congo-Kinshasa: Ebola Outbreak Worsens
The Democratic Republic of Congo has launched a clinical trial of experimental Ebola treatments as the outbreak continues to spread in the north-east of the country.
- STAT+: How a biotech turned a trial failure into an AI model
A biotech company transformed a failed clinical trial into an AI model, as reported in STAT's Health Tech newsletter. The article discusses how this approach is being used in the life sciences technology sector.
- Scientists finally crack an “undruggable” pancreatic cancer target and nearly double survival
Scientists have developed a drug, daraxonrasib, targeting the KRAS mutation in pancreatic cancer, which was previously considered undruggable. The drug nearly doubled survival rates for patients with advanced pancreatic cancer and reduced the risk of death by 60% in a major clinical trial.
- Wonder pill shrinks tumours in a third of patients with six hard-to-treat cancers, early trial shows
An experimental 'wonder pill' reduced tumors in one-third of patients with six challenging-to-treat cancers, according to an early-stage clinical trial. The results suggest potential therapeutic promise for these aggressive cancer types.
- Daily pill can double survival time for deadliest cancer, trial shows
A daily pill called Daraxonrasib was found to double survival time for pancreatic cancer patients in a clinical trial, according to a study. The treatment shows significant improvement in outcomes for the deadliest form of cancer.
- Daily pill can double survival time for world’s deadliest cancer, trial shows
A daily pill called daraxonrasib can double survival time for patients with advanced pancreatic cancer, according to a clinical trial hailed as a 'gamechanger' by experts. Pancreatic cancer is described as the world’s deadliest cancer with few effective treatments.
- Scientists discover simple way to relieve arthritis pain without pills or surgery
Researchers discovered that a simple walking technique involving a slight foot angle adjustment can effectively reduce knee osteoarthritis pain in a year-long clinical trial. This non-invasive method proved as effective as common medications while also slowing cartilage damage in the joint.
- Scientists say a daily multivitamin may help slow aging
A daily multivitamin may help slow biological aging in older adults, with participants showing slower aging after two years. The effect was equivalent to about four months less biological aging. People who were biologically older than their actual age benefited the most.
- FDA expanding access to pancreatic cancer drug to some patients
The FDA announced it is expanding access to a pancreatic cancer drug that showed nearly doubled survival time for patients with advanced pancreatic cancer in a large clinical trial. This decision aims to provide earlier access to the promising treatment.
- Simple “gut reset” may stop weight gain after Ozempic or Wegovy
A new minimally invasive procedure called duodenal mucosal resurfacing may help prevent weight regain after discontinuing Ozempic or Wegovy. Clinical trials showed participants who underwent the treatment regained less weight compared to others, as the procedure renews the upper small intestine lining and potentially resets metabolism.
- Groundbreaking bowel cancer trial follow-up shows zero relapses
A groundbreaking bowel cancer trial follow-up reported zero relapses among participants, indicating potential long-term success. The study suggests that the treatment may prevent cancer recurrence effectively.
- Pancreatic cancer mRNA vaccine shows lasting results in an early trial
An mRNA vaccine for pancreatic cancer has shown lasting results in an early clinical trial, offering potential new treatment options. The trial's success highlights the vaccine's ability to target the disease effectively.
- This cheap drug could help people with type 1 diabetes use less insulin
A clinical trial found that metformin, a low-cost drug used for type 2 diabetes, may help type 1 diabetes patients reduce insulin usage by 12% while maintaining stable blood sugar levels. The drug's mechanism was unexpected, as researchers initially aimed to address insulin resistance.
- This method to reverse cellular ageing is about to be tested in humans
A clinical trial is set to begin testing a method to reverse cellular ageing in humans, aiming to rejuvenate aged tissues and organs. The study, published in Nature, explores whether dialing back cell development can be safely applied to human tissues.
- This 5-day diet helped Crohn’s patients feel better fast
A new clinical trial shows that a five-day monthly fasting-mimicking diet can reduce symptoms and inflammation markers in Crohn’s disease patients.